Analytical Data
-
基因名
CD9
- Application
-
种属
Mouse
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P40240
-
表达区间
110-193aa
-
分子量
17.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CD9 is a member of the tetraspanin family of proteins that plays a crucial role in various cellular processes, including cell adhesion, migration, and signaling. It is widely expressed across different tissues and is particularly notable for its involvement in immune responses and reproductive biology. Research has shown that CD9 interacts with various membrane proteins, thereby influencing cellular functions and the formation of specialized microdomains known as tetraspanin-enriched microdomains (TEMs). These interactions are critical for the modulation of cell signaling pathways and have implications in cancer progression, as alterations in CD9 expression levels have been linked to metastasis and tumor development. In recent years, recombinant CD9 proteins have been developed to explore their roles in biological processes and to assess their potential as therapeutic targets. Studies utilizing these recombinant proteins have provided insights into the mechanisms of CD9-mediated cellular functions, paving the way for novel strategies in cancer therapy and regenerative medicine. By elucidating the interactions and pathways involving CD9, researchers aim to harness its biological properties for clinical applications, including immunotherapy and drug delivery systems. Thus, the investigation of CD9 recombinant proteins is not only fundamental for understanding its biology but also holds promise for improving therapeutic approaches in various diseases.
